Company Profile
Infinity Pharmaceuticals Stock Price, News & Analysis
- Ticker:
- INFI
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for INFI.
Company overview
Business overview
Infinity Pharmaceuticals was an oncology company focused on immuno-oncology and targeted cancer programs before becoming a legacy biotech ticker. Its story was defined by the difficulty of sustaining momentum in a crowded oncology market.
Geographic Base and Sector Classification
Infinity was headquartered in the United States and listed on NASDAQ. It sat in small-cap oncology biotechnology.
Business Model Characteristics
The business depended on clinical data, strategic updates, and capital efficiency while advancing a narrow pipeline. Investors historically watched whether the company could produce differentiated cancer assets.
Position Within the Biotechnology Landscape
Infinity is best viewed as a historical oncology biotech name. It belongs to the category of small-cap companies where scientific promise was often not enough without capital and execution.
Future catalysts
Infinity Pharmaceuticals is now a legacy / closeout story, so the catalysts are any residual asset or corporate-resolution update. There is no broad live pipeline left.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Infinity Pharmaceuticals do?
Infinity Pharmaceuticals was an oncology company focused on immuno-oncology and targeted cancer programs before becoming a legacy biotech ticker. Its story was defined by the difficulty of sustaining momentum in a crowded oncology market.
On which exchange is INFI stock listed?
Infinity Pharmaceuticals (INFI) is associated with NASDAQ, United States, Biopharma.
What is Infinity?
Infinity Pharmaceuticals is now a legacy / closeout story, so the catalysts are any residual asset or corporate-resolution update.
Which conditions is Infinity Pharmaceuticals targeting with Infinity?
Infinity Pharmaceuticals is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
How does Infinity Pharmaceuticals describe recent progress with Infinity?
Infinity Pharmaceuticals is now a legacy / closeout story, so the catalysts are any residual asset or corporate-resolution update.
What is Pharmaceuticals?
Infinity Pharmaceuticals was an oncology company focused on immuno-oncology and targeted cancer programs before becoming a legacy biotech ticker.
What should investors watch for with Pharmaceuticals?
Infinity Pharmaceuticals is now a legacy / closeout story, so the catalysts are any residual asset or corporate-resolution update.
What is There?
There is no broad live pipeline left.